Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL)
Clinical trial NCT05366257 · COMPLETED
Trial details
- NCT number
- NCT05366257
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-17
- Primary completion
- 2021-05-10
- Enrollment
- 160602
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.